Literature DB >> 23302548

Atypical diabetes in children: ketosis-prone type 2 diabetes.

Atul Vaibhav1, Mathew Mathai, Shaun Gorman.   

Abstract

Ketosis-prone type 2 diabetes mellitus also known as atypical or flatbush diabetes is being increasingly recognised worldwide. These patients are typically obese, middle-aged men with a strong family history of type 2 diabetes. The aetiology and pathophysiological mechanism is still unclear but some initial research suggests that patients with ketosis-prone type 2 diabetes have a unique predisposition to glucose desensitisation. These patients have negative autoantibodies typically associated with type 1 diabetes but have shown to have human leucocyte antigen (HLA) positivity. At initial presentation, there is an impairment of both insulin secretion and action. β Cell function and insulin sensitivity can be markedly improved by initiating aggressive diabetes management to allow for discontinuation of insulin therapy within a few months of treatment. These patients can be maintained on oral hypoglycaemic agents and insulin therapy can be safely discontinued after few months depending on their β cell function.

Entities:  

Mesh:

Year:  2013        PMID: 23302548      PMCID: PMC3604177          DOI: 10.1136/bcr-2012-007704

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  Diabetic ketoacidosis in young obese Japanese men.

Authors:  K Yamada; K Nonaka
Journal:  Diabetes Care       Date:  1996-06       Impact factor: 19.112

2.  Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.

Authors:  S I McFarlane; R L Chaiken; S Hirsch; P Harrington; H E Lebovitz; M A Banerji
Journal:  Diabet Med       Date:  2001-01       Impact factor: 4.359

3.  Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience.

Authors:  A Piñero-Piloña; P Litonjua; L Aviles-Santa; P Raskin
Journal:  Diabetes Care       Date:  2001-06       Impact factor: 19.112

4.  Accuracy and predictive value of classification schemes for ketosis-prone diabetes.

Authors:  Ashok Balasubramanyam; Gilberto Garza; Lucille Rodriguez; Christiane S Hampe; Lakshmi Gaur; Ake Lernmark; Mario R Maldonado
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

5.  Hyperglycemic crises in urban blacks.

Authors:  G E Umpierrez; J P Kelly; J E Navarrete; M M Casals; A E Kitabchi
Journal:  Arch Intern Med       Date:  1997-03-24

6.  Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis.

Authors:  G E Umpierrez; W Woo; W A Hagopian; S D Isaacs; J P Palmer; L K Gaur; G T Nepom; W S Clark; P S Mixon; A E Kitabchi
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

7.  Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus.

Authors:  K C Tan; I R Mackay; P Z Zimmet; B R Hawkins; K S Lam
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

8.  Maturity-onset diabetes of youth in black Americans.

Authors:  W E Winter; N K Maclaren; W J Riley; D W Clarke; M S Kappy; R P Spillar
Journal:  N Engl J Med       Date:  1987-02-05       Impact factor: 91.245

9.  The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults.

Authors:  S A Westphal
Journal:  Am J Med       Date:  1996-07       Impact factor: 4.965

10.  Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.

Authors:  G E Umpierrez; W S Clark; M T Steen
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

View more
  2 in total

1.  An Insight Into Flatbush Diabetes: A Rare Form of Diabetes.

Authors:  Malavika Shankar; Tutul Chowdhury; Nicole Gousy; Ashwaghosha Parthasarathi
Journal:  Cureus       Date:  2022-01-24

2.  A Pediatric Case of Ketosis-Prone Type 2 Diabetes Requiring Insulin Therapy.

Authors:  Misa Matsuura; Daisuke Sugawara; Ko Ichihashi
Journal:  Cureus       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.